Difference between revisions of "Team:UCSC/Part Collection"

(Prototype team page)
 
Line 1: Line 1:
{{UCSC}}
+
{{UCSC-Header}}
 +
 
 
<html>
 
<html>
  
 +
<script src="https://use.typekit.net/hii0ztv.js"></script>
 +
<script>try{Typekit.load({ async: true });}catch(e){}</script>
  
 +
<style>
  
 +
.metabolic-pathway {
 +
  margin: auto;
 +
  background: honeydew;
 +
  width: 100%;
 +
}
  
<div class="column full_size judges-will-not-evaluate">
+
h1 {
<h3>★  ALERT! </h3>
+
  font-family: 'objektiv-mk1'!important;
<p>This page is used by the judges to evaluate your team for the <a href="https://2017.igem.org/Judging/Medals">medal criterion</a> or <a href="https://2017.igem.org/Judging/Awards"> award listed above</a>. </p>
+
  font-size: 300%; /*!important*/
<p> Delete this box in order to be evaluated for this medal criterion and/or award. See more information at <a href="https://2017.igem.org/Judging/Pages_for_Awards"> Instructions for Pages for awards</a>.</p>
+
  font-weight: 300 !important;
</div>
+
    width: 90%;
<div class="clear"></div>
+
}
  
 +
h2 {
 +
  font-family: 'objektiv-mk1' !important;
 +
  font-size: 200%;
 +
  font-weight: 300;
 +
}
  
 +
h3 {
 +
  font-family: 'objektiv-mk1' !important;
 +
  font-size: 120%;
 +
  font-weight: 400;
 +
}
  
 +
#page {
 +
  background: honeydew;
 +
}
  
 +
.proj-button {
 +
    position: relative;
 +
    width: 25%;
 +
    text-decoration: none !important;
 +
}
  
<div class="column full_size">
+
.proj-button-image {
 +
  opacity: 1;
 +
  display: inline-block;
 +
  width: 30%;
 +
  height: auto;
 +
  transition: .5s ease;
 +
  backface-visibility: hidden;
 +
}
  
 +
.proj-button-image-solo {
 +
  opacity: 1;
 +
  display: inline-block;
 +
  width: 65%;
 +
  height: auto;
 +
  transition: .5s ease;
 +
  backface-visibility: hidden;
 +
}
  
<h1> Part Collection </h1>
+
.proj-button-desc {
 +
  transition: .5s ease;
 +
  opacity: 0;
 +
  position: absolute;
 +
  top: 100%;
 +
  left: 50%;
 +
  background: transparent;
 +
  transform: translate(-50%, -50%);
 +
  -ms-transform: translate(-50%, -50%)
 +
}
  
 +
.overlap-button-text {
 +
  background-color: transparent;
 +
  color: black;
 +
  font-size: 20px;
 +
  font-family: "Objektiv-mk1" !important;
 +
  font-weight: 400 !important;
 +
  padding: 16px 32px;
 +
}
  
<p>Did your team make a lot of great parts? Is there a theme that ties all your parts together? Do you have more than 10 parts in this collection? Did you make a CRISPR collection, a MoClo collection, or a collection of awesome pigment parts? Describe your parts collection on this page, so the judges can evaluate you for the Best Part Collection award.</p>
+
.proj-button:hover .proj-button-image {
 +
  opacity: 0.3;
 +
}
  
<p>
+
.proj-button:hover .proj-button-image-solo {
While you should put all the characterization information for your parts on the Registry, you are encouraged to explain how all your parts form a collection on this page.  
+
  opacity: 0.3;
</p>
+
}
 +
 
 +
.proj-button:hover .proj-button-desc {
 +
  opacity: 0.6;
 +
}
 +
 
 +
.text {
 +
  background-color: transparent;
 +
  color: black;
 +
  font-size: 20px;
 +
  padding: 16px 32px;
 +
}
 +
 
 +
.paragraph-left {
 +
  font-family: 'objektiv-mk1' !important;
 +
  font-size: 18px;
 +
  text-align: left;
 +
  vertical-align: middle;
 +
}
 +
 
 +
p {
 +
  font-family: 'objektiv-mk1' !important;
 +
/*  margin-left: 200px !important;
 +
  margin-right: 200px !important;*/
 +
  font-size: large !important;
 +
}
 +
 
 +
.firstword {
 +
  font-family: 'objektiv-mk1' !important;
 +
  font-size: 65px;
 +
}
 +
.quote {
 +
  font-family: 'objektiv-mk1' !important;
 +
  font-style: italic !important;
 +
  font-size: 28px;
 +
  line-height: 130%;
 +
}
 +
 
 +
.quote-person {
 +
  font-family: 'objektiv-mk1' !important;
 +
  font-size: 22px;
 +
  width: 100% !important;
 +
  text-align: right !important;
 +
  padding-right: 80px !important;
 +
}
 +
 
 +
.titleimg {
 +
  vertical-align: middle;
 +
  width: 24%;
 +
  padding-left: 10px;
 +
}
 +
 
 +
.titleimg-medal {
 +
  vertical-align: middle;
 +
  width: 14%;
 +
  padding-right: 10px;
 +
}
 +
 
 +
.titlebox {
 +
  margin-left: 0px !important;
 +
}
 +
 
 +
.reference-list {
 +
  font-family: 'objektiv-mk1';
 +
  font-size: 12px;
 +
  text-align: left;
 +
  list-style-type: none;
 +
  line-height: 100%;
 +
  margin-bottom: 80px;
 +
}
 +
 
 +
.reference-italic {
 +
  font-family: 'objektiv-mk1';
 +
  font-size: 12px;
 +
  font-style: italic;
 +
}
 +
 
 +
figcaption {
 +
  font-family: 'objektiv-mk1';
 +
  font-style: italic;
 +
  font-size: 13px;
 +
}
 +
 
 +
.diagram-image-right-1 {
 +
  width: 45%;
 +
  padding-left: 30px;
 +
  float: right;
 +
  text-align: center;
 +
  font-family: 'objektiv-mk1';
 +
  padding-bottom: 15px;
 +
  padding-top: 0px;
 +
}
 +
 
 +
.diagram-image-right-2 {
 +
  width: 45%;
 +
  padding-left: 30px;
 +
  float: right;
 +
  text-align: center;
 +
  font-family: 'objektiv-mk1';
 +
  padding-bottom: 5px;
 +
}
 +
 
 +
.diagram-image-left-1 {
 +
  width: 68%;
 +
  padding-right: 30px;
 +
  float: left;
 +
  text-align: center;
 +
  font-family: 'objektiv-mk1';
 +
  padding-bottom: 110px;
 +
  padding-top: 30px;
 +
}
 +
 
 +
.diagram-image-left-2 {
 +
  width: 52%;
 +
  padding-right: 30px;
 +
  float: left;
 +
  text-align: center;
 +
  font-family: 'objektiv-mk1';
 +
  padding-bottom: 5px;
 +
  padding-top: 15px;
 +
}
 +
 
 +
.diagram-image-center-large-1 {
 +
  width: 100%;
 +
  align-content: center;
 +
  text-align: center;
 +
  font-family: 'objektiv-mk1';
 +
  padding-bottom: 15px;
 +
  padding-top: 15px;
 +
    margin-right: 100px;
 +
}
 +
 
 +
.row-3 {
 +
  font-family: 'objektiv-mk1';
 +
  font-size: inherit;
 +
}
 +
 
 +
@media (min-width: 1450px) {
 +
  .diagram-image-left-1 {
 +
    width: 68%;
 +
    padding-right: 30px;
 +
    float: left;
 +
    text-align: center;
 +
    font-family: 'objektiv-mk1';
 +
    padding-bottom: 150px;
 +
    padding-top: 95px;
 +
  }
 +
 
 +
}
 +
 
 +
@media (min-width: 1285px) {
 +
  .diagram-image-left-1 {
 +
    width: 68%;
 +
    padding-right: 30px;
 +
    float: left;
 +
    text-align: center;
 +
    font-family: 'objektiv-mk1';
 +
    padding-bottom: 40px;
 +
    padding-top: 95px;
 +
  }
 +
 
 +
}
 +
 
 +
@media (min-width: 1144px) {
 +
  .container {
 +
      width: 100% !important;
 +
    }
 +
    .container-3 {
 +
      width: 100% !important;
 +
      font-family: 'objektiv-mk1';
 +
    }
 +
 
 +
  .text-container {
 +
    width: 70%;
 +
    padding-left: 15px;
 +
    padding-right: 15px;
 +
  }
 +
 
 +
  .titlebox {
 +
    width: 80%;
 +
  }
 +
 
 +
  figcaption {
 +
    font-size: 16px;
 +
  }
 +
}
 +
 
 +
@media (max-width: 1144px) {
 +
 
 +
    .titlebox {
 +
      margin-left: auto !important;
 +
    }
 +
 
 +
  p {
 +
    font-family: 'objektiv-mk1' !important;
 +
    margin-left: 10px !important;
 +
    margin-right: 10px !important;
 +
    font-size: medium !important;
 +
  }
 +
 
 +
  .quote {
 +
    font-family: 'objektiv-mk1' !important;
 +
    font-style: italic !important;
 +
    font-size: 26px;
 +
  }
 +
 
 +
  .quote-person {
 +
    font-family: 'objektiv-mk1' !important;
 +
    font-size: 20px;
 +
    width: 100%;
 +
    text-align: right;
 +
    padding-right: 80px !important;
 +
  }
 +
 
 +
  .metabolic-pathway {
 +
      margin: auto;
 +
      background: honeydew;
 +
      width: 100%;
 +
  }
 +
 
 +
  .container {
 +
    width: 80% !important;
 +
    padding-left: 0px !important;
 +
    padding-right: 0px !important;
 +
  }
 +
 
 +
  .container-3 {
 +
    width: 80% !important;
 +
    padding-left: 0px !important;
 +
    padding-right: 0px !important;
 +
    font-family: 'objektiv-mk1';
 +
  }
 +
 
 +
  .text-container {
 +
    width: 80%;
 +
    padding-left: 0px;
 +
    padding-right: 0px;
 +
  }
 +
 
 +
  figcaption {
 +
    font-size: 14px;
 +
  }
 +
 
 +
  .diagram-image-center-large-1 {
 +
    width: 100%;
 +
    align-content: center;
 +
    text-align: center;
 +
    font-family: 'objektiv-mk1';
 +
    padding-bottom: 15px;
 +
    padding-top: 15px;
 +
      margin-right: 60px;
 +
    }
 +
 
 +
    .diagram-image-left-1 {
 +
    width: 50%;
 +
    padding-right: 30px;
 +
    float: left;
 +
    text-align: center;
 +
    font-family: 'objektiv-mk1';
 +
    padding-bottom: 30px;
 +
    padding-top: 30px;
 +
  }
 +
}
 +
 
 +
@media (max-width: 992px) {
 +
  .proj-button-image-solo {
 +
      opacity: 1;
 +
      display: inline-block;
 +
      width: 30%;
 +
      height: auto;
 +
      transition: .5s ease;
 +
      backface-visibility: hidden;
 +
    }
 +
 
 +
    .diagram-image-center-large-1 {
 +
    width: 100%;
 +
    align-content: center;
 +
    text-align: center;
 +
    font-family: 'objektiv-mk1';
 +
    padding-bottom: 15px;
 +
    padding-top: 15px;
 +
    margin-left: 60px;
 +
      margin-right: 60px;
 +
    }
 +
}
 +
 
 +
@media (max-width: 768px) {
 +
  .proj-button-image {
 +
      opacity: 1;
 +
      display: inline-block;
 +
      width: 32%;
 +
      height: auto;
 +
      transition: .5s ease;
 +
      backface-visibility: hidden;
 +
    }
 +
 
 +
    .proj-button-image-solo {
 +
      opacity: 1;
 +
      display: inline-block;
 +
      width: 35%;
 +
      height: auto;
 +
      transition: .5s ease;
 +
      backface-visibility: hidden;
 +
    }
 +
 
 +
    .proj-button-desc {
 +
      transition: .5s ease;
 +
      opacity: 1;
 +
      position: absolute;
 +
      top: 100%;
 +
      left: 50%;
 +
      transform: translate(-50%, -50%);
 +
      -ms-transform: translate(-50%, -50%)
 +
  }
 +
 
 +
    .diagram-image-right-1 {
 +
    padding-left: 10px;
 +
    padding-right: 10px;
 +
    font-size: 65%;
 +
    line-height: 1.5;
 +
    width: 65%;
 +
}
 +
 
 +
  .diagram-image-left-1 {
 +
    padding-right: 10px;
 +
    padding-left: 10px;
 +
    font-size: 65%;
 +
    line-height: 1.5;
 +
    width: 68%;
 +
}
 +
 
 +
  .diagram-image-right-2 {
 +
    padding-left: 10px;
 +
    padding-right: 10px;
 +
    font-size: 65%;
 +
    line-height: 1.5;
 +
}
 +
 
 +
  .diagram-image-left-2 {
 +
    padding-right: 10px;
 +
    padding-left: 10px;
 +
    font-size: 65%;
 +
    line-height: 1.5;
 +
}
 +
 
 +
  .diagram-image-center-large-1 {
 +
    width: 100%;
 +
    align-content: center;
 +
    text-align: center;
 +
    font-family: 'objektiv-mk1';
 +
    padding-bottom: 15px;
 +
    padding-top: 15px;
 +
    font-size: 65%;
 +
    line-height: 1.5;
 +
  }
 +
 
 +
  .overlap-button-text {
 +
    background-color: rgba(94, 94, 94, 0.4);
 +
    border-radius: 60px;
 +
    color: white;
 +
  }
 +
 
 +
  h1 {
 +
      font-family: 'objektiv-mk1'; /*!important*/
 +
      font-size: 220%; /*!important*/
 +
      width: 80%;
 +
  }
 +
 
 +
    h2 {
 +
      font-family: 'objektiv-mk1'; /*!important*/
 +
      font-size: 20px; /*!important*/
 +
  }
 +
 
 +
  /*h3 {
 +
    font-size: 80% !important;
 +
  }*/
 +
 
 +
  .quote {
 +
    font-family: 'objektiv-mk1' !important;
 +
    font-style: italic !important;
 +
    font-size: 20px;
 +
  }
 +
 
 +
  .quote-person {
 +
    width: 100%;
 +
    font-family: 'objektiv-mk1' !important;
 +
    font-size: 16px;
 +
    text-align: right !important;
 +
    padding-right: 20px !important;
 +
  }
 +
 
 +
  .text-container {
 +
    width: 82%;
 +
    padding-left: 0px;
 +
    padding-right: 0px;
 +
  }
 +
 
 +
  figcaption {
 +
    font-size: 14px;
 +
    line-height: 140%;
 +
  }
 +
 
 +
  .reference-list {
 +
    font-family: 'objektiv-mk1';
 +
    font-size: 12px;
 +
    text-align: left;
 +
    list-style-type: none;
 +
    line-height: 100%;
 +
    margin-bottom: 80px;
 +
    margin-right: -70px;
 +
    margin-left: -70px;
 +
  }
 +
 
 +
  .diagram-image {
 +
    width: 100%;
 +
    padding-left: 0px;
 +
  }
 +
 
 +
  .container-3 {
 +
    font-family: 'objektiv-mk1';
 +
    font-size: 65%;
 +
    line-height: 1.5;
 +
  }
 +
 
 +
  .row-3 {
 +
    font-family: 'objektiv-mk1';
 +
    font-size: 75%;
 +
    line-height: 1.5;
 +
  }
 +
}
 +
/*  p {
 +
    margin-left: 10px !important;
 +
    margin-right: 10px !important;
 +
  }
 +
}*/
 +
 
 +
@media (max-width: 576px) {
 +
  .proj-button-image {
 +
      opacity: 1;
 +
      display: inline-block;
 +
      width: 50%;
 +
      height: auto;
 +
      transition: .5s ease;
 +
      backface-visibility: hidden;
 +
    }
 +
 
 +
    .proj-button-image-solo {
 +
      opacity: 1;
 +
      display: inline-block;
 +
      width: 50%;
 +
      height: auto;
 +
      transition: .5s ease;
 +
      backface-visibility: hidden;
 +
    }
 +
 
 +
    .proj-button-desc {
 +
      transition: .5s ease;
 +
      opacity: 1;
 +
      position: absolute;
 +
      top: 100%;
 +
      left: 50%;
 +
      transform: translate(-50%, -50%);
 +
      -ms-transform: translate(-50%, -50%)
 +
  }
 +
 
 +
    .overlap-button-text {
 +
    background-color: rgba(94, 94, 94, 0.5);
 +
    border-radius: 60px;
 +
    color: white;
 +
    font-size: 12px;
 +
  }
 +
 
 +
  .firstword {
 +
    font-family: 'objektiv-mk1' !important;
 +
    font-size: 40px;
 +
  }
 +
 
 +
  .titleimg {
 +
    vertical-align: middle;
 +
    width: 40%;
 +
    padding-left: 5px;
 +
  }
 +
 
 +
  .titleimg-medal {
 +
  vertical-align: middle;
 +
  width: 30%;
 +
  padding-right: 5px;
 +
}
 +
 
 +
  p {
 +
    font-family: 'objektiv-mk1' !important;
 +
    margin-left: 10px !important;
 +
    margin-right: 10px !important;
 +
    font-size: small !important;
 +
  }
 +
 
 +
  h1 {
 +
    font-size: 140%;
 +
  }
 +
 
 +
  .quote {
 +
    font-family: 'objektiv-mk1' !important;
 +
    font-style: italic !important;
 +
    font-size: 17px;
 +
  }
 +
 
 +
  .quote-person {
 +
    width: 60% !important;
 +
    font-family: 'objektiv-mk1' !important;
 +
    font-size: 12px;
 +
    text-align: right !important;
 +
    margin-right: -120px !important;
 +
  }
 +
 
 +
  .paragraph-left {
 +
    font-size: 13px;
 +
    line-height: 170%;
 +
  }
 +
 
 +
  .text-container {
 +
    width: 85%;
 +
    padding-left: 0px;
 +
    padding-right: 0px;
 +
  }
 +
 
 +
  .metabolic-pathway {
 +
      margin: auto;
 +
      background: honeydew;
 +
      width: 110%;
 +
      margin-left: -20px;
 +
      margin-right: -20px;
 +
  }
 +
 
 +
  figcaption {
 +
    font-size: 12px;
 +
    line-height: 130%;
 +
  }
 +
 
 +
  .reference-list {
 +
    font-family: 'objektiv-mk1';
 +
    font-size: 12px;
 +
    text-align: left;
 +
    list-style-type: none;
 +
    line-height: 100%;
 +
    margin-bottom: 80px;
 +
    margin-right: -50px;
 +
    margin-left: -50px;
 +
  }
 +
}
 +
 
 +
@media (max-width: 400px) {
 +
  .quote {
 +
    font-size: 15px;
 +
  }
 +
}
 +
 
 +
 
 +
</style>
 +
 
 +
<body style="background-color: honeydew;">
 +
<div id="page">
 +
<center>
 
<br>
 
<br>
<h3>Best Part Collection Special Prize</h3>
 
<p>Did your team make a lot of great parts? Is there a team that ties all your parts together? Do you have more than 10 parts in this collection? Did you make a CRISPR collection, a MoClo collection or a collection of awesome pigment parts? Tell the judges you should be evaluated for the Best Parts Collection award! To be eligible for this award, these parts must adhere to <a href="http://parts.igem.org/DNA_Submission">Registry sample submission guidelines</a> and have been sent to the Registry of Standard Biological Parts.
 
<br><br>
 
If you have a collection of parts you wish to nominate your team for this <a href="https://2017.igem.org/Judging/Awards">special prize</a>, make sure you add your part numbers to your <a href="https://2017.igem.org/Judging/Judging_Form">judging form</a> and delete the box at the top of this page.</p>
 
 
<br>
 
<br>
  
 +
<img class="titleimg" src="https://static.igem.org/mediawiki/2017/7/79/Parts.png">
  
 +
<h1>PARTS</h1>
  
<div class="highlight">
+
<br>
<h4>Note</h4>
+
<p>This page should list all the parts in the collection your team made during your project. You must add all characterization information for your parts on the Registry. You should not put characterization information on this page.</p>
+
  
</div>
+
<div class="text-container">
  
</div>
+
  <br>
  
 +
  <h2 style="text-align: left; font-weight: 500;">BBa_k2223000: <i>4abh</i></h2>
 +
 +
  <br>
 +
 +
  <p>The <i>4abh</i> gene, native to <i>A. bisporus</i>, allows the conversion of molecules like anthranilate and para-aminobenzoic acid to 4-aminophenol.</p>
 +
 +
  <br>
 +
  <br>
 +
 +
  <h2 style="text-align: left; font-weight: 500;">BBa_k2223001: <i>nhoA</i></h2>
 +
 +
  <br>
 +
 +
  <p>The <i>nhoA</i> gene is native to <i>E. coli</i> and allows for the conversion of 4-aminophenol to acetaminophen.</p>
 +
 +
  <br>
 +
  <br>
 +
 +
  <h2 style="text-align: left; font-weight: 500;">BBa_k2223002: <i>ssuE</i></h2>
 +
 +
  <br>
 +
 +
  <p>The enzyme created by the gene <i>ssuE</i> catalyzes activity that reduces the Flavin mononucleotide (FMN) by using NADH dehydrogenase as a reducing agent. This gene sequenced was optimized from <i>S. elonagtus</i> PCC 7002 sequence.</p>
 +
 +
  <br>
 +
  <br>
 +
 +
  <h2 style="text-align: left; font-weight: 500;">BBa_k2223003: <i>bluB</i></h2>
 +
 +
  <br>
 +
 +
  <p>The gene <i>bluB</i>  encodes an enzyme that catalyzes an oxidized reaction that cleaves the reduced Flavin mononucleotide (FMNH<sub>2</sub>) transforming to 5,6-dimethylbenzimidazole (5,6-DMB). The <i>bluB</i> sequence was optimized for PCC 7942 using the reference genome sequence from <i>Sinorhizobium meliloti</i> 1021.</p>
 +
 +
  <br>
 +
  <br>
 +
 +
  <h2 style="text-align: left; font-weight: 500;">BBa_k2223004: riboswitch</h2>
 +
 +
  <br>
 +
 +
  <p>The riboswitch part contains a psbAI promoter which transcribes an mRNA strand consisting of a riboswitch and repressor gene, TetR. The riboswitch binds to vitamin B<sub>12</sub> and regulates the expression of the downstream repressor gene. In the presence of vitamin B<sub>12</sub>, the riboswitch specifically anneals onto the cobalamin molecule inducing a conformational change within the mRNA sequestering the riboswitch binding site upstream of TetR. However, in the absence of vitamin B<sub>12</sub>, TetR is continuously expressed.</p>
 +
 +
  <br>
 +
  <br>
 +
 +
  <h2 style="text-align: left; font-weight: 500;">BBa_k2223005: riboswitch_reporter</h2>
 +
 +
  <br>
 +
 +
  <p>The riboswitch_reporter part contains a psbAI promoter which transcribes an mRNA strand consisting of a Tet operator, TetO, upstream of the reporter gene, mRFP. The reporter is trans-regulated by a Tet repressor protein bound to the Tet operator hindering translation. In the presence of vitamin B<sub>12</sub> the Tet systems renders useless thus, mRFP is expressed.</p>
 +
 +
  <br>
 +
  <br>
 +
  <br>
 +
  <br>
 +
 +
  <div class="container" style="width: 100%">
 +
    <div class="row">
 +
      <div class="col-md-4">
 +
        <h3>P R O J E C T</h3>
 +
        <hr>
 +
        <a href="https://2017.igem.org/Team:UCSC/Project" class="proj-button">
 +
          <img src="https://static.igem.org/mediawiki/2017/6/64/UCSCproject.png" class="proj-button-image-solo" alt="https://m.signalvnoise.com/depend-less-on-each-other-507fe0e23e4b">
 +
          <div class="proj-button-desc">
 +
            <div class="overlap-button-text">HOMEPAGE</div>
 +
          </div>
 +
        </a>
 +
      </div>
 +
 +
      <div class="col-md-8">
 +
        <h3>Click here to learn more!</h3>
 +
        <hr>
 +
        <div class="row">
 +
 +
        <a href="https://2017.igem.org/Team:UCSC/Acetaminophen" class="proj-button">
 +
              <img src="https://static.igem.org/mediawiki/2017/6/6c/Acetaminophenicon.png" class="proj-button-image">
 +
              <div class="proj-button-desc">
 +
                <div class="overlap-button-text">ACETAMINOPHEN</div>
 +
              </div>
 +
          </a>
 +
 +
        <a href="https://2017.igem.org/Team:UCSC/B-12" class="proj-button">
 +
              <img src="https://static.igem.org/mediawiki/2017/8/89/B12_title.png" class="proj-button-image">
 +
              <div class="proj-button-desc">
 +
                <div class="overlap-button-text">VITAMIN B<sub>12</sub></div>
 +
              </div>
 +
          </a>
 +
 +
          <a href="https://2017.igem.org/Team:UCSC/Model" class="proj-button">
 +
              <img src="https://static.igem.org/mediawiki/2017/b/be/Modeling_button.png" class="proj-button-image">
 +
            <div class="proj-button-desc">
 +
                <div class="overlap-button-text">MODELING</div>
 +
              </div>
 +
          </a>
 +
          </div>
 +
          <div class="row">
 +
 +
          <a href="https://2017.igem.org/Team:UCSC/Demonstrate" class="proj-button">
 +
            <img src="https://static.igem.org/mediawiki/2017/a/ad/Resulticon.png" class="proj-button-image">
 +
            <div class="proj-button-desc">
 +
              <div class="overlap-button-text">RESULTS</div>
 +
            </div>
 +
        </a>
 +
 +
        <a href="https://2017.igem.org/Team:UCSC/Target-Organism" class="proj-button">
 +
            <img src="https://static.igem.org/mediawiki/2017/8/84/Spirulinaicon.png" class="proj-button-image">
 +
            <div class="proj-button-desc">
 +
              <div class="overlap-button-text">TARGET ORGANISM</div>
 +
            </div>
 +
        </a>
 +
      </div>
 +
    </div>
 +
  </div>
 +
<br>
 +
<br>
 +
 +
</div>
 +
</div>
 +
</center>
 +
</div>
 
</html>
 
</html>
 +
{{UCSC-Footer}}

Revision as of 00:03, 2 November 2017



PARTS



BBa_k2223000: 4abh


The 4abh gene, native to A. bisporus, allows the conversion of molecules like anthranilate and para-aminobenzoic acid to 4-aminophenol.



BBa_k2223001: nhoA


The nhoA gene is native to E. coli and allows for the conversion of 4-aminophenol to acetaminophen.



BBa_k2223002: ssuE


The enzyme created by the gene ssuE catalyzes activity that reduces the Flavin mononucleotide (FMN) by using NADH dehydrogenase as a reducing agent. This gene sequenced was optimized from S. elonagtus PCC 7002 sequence.



BBa_k2223003: bluB


The gene bluB encodes an enzyme that catalyzes an oxidized reaction that cleaves the reduced Flavin mononucleotide (FMNH2) transforming to 5,6-dimethylbenzimidazole (5,6-DMB). The bluB sequence was optimized for PCC 7942 using the reference genome sequence from Sinorhizobium meliloti 1021.



BBa_k2223004: riboswitch


The riboswitch part contains a psbAI promoter which transcribes an mRNA strand consisting of a riboswitch and repressor gene, TetR. The riboswitch binds to vitamin B12 and regulates the expression of the downstream repressor gene. In the presence of vitamin B12, the riboswitch specifically anneals onto the cobalamin molecule inducing a conformational change within the mRNA sequestering the riboswitch binding site upstream of TetR. However, in the absence of vitamin B12, TetR is continuously expressed.



BBa_k2223005: riboswitch_reporter


The riboswitch_reporter part contains a psbAI promoter which transcribes an mRNA strand consisting of a Tet operator, TetO, upstream of the reporter gene, mRFP. The reporter is trans-regulated by a Tet repressor protein bound to the Tet operator hindering translation. In the presence of vitamin B12 the Tet systems renders useless thus, mRFP is expressed.